Our mission is bold: to collaboratively optimize and accelerate the development of new cancer therapies for the benefit of patients of all ages.
We aim to achieve this by integrating patient data and materials -including patient-derived organoid models- and artificial intelligence at early stages of preclinical therapy development, across four pipelines focused on developing oncology-targeted therapeutics:
- Small molecules,
- Biologics,
- Cell and gene therapies, and
- Therapeutic vaccines.
Our world-class toolbox of state-of-the-art technologies, is available through Demonstrator Projects to anyone globally that has a target of interest and/or a validated hit, and who wishes to advance their asset to a valuable clinical candidate. Ultimately, our integrated approach and top notch infrastructure should result in more effective, personalized cancer therapies. This will bring us closer to our overarching goal: to outsmart cancer and impact lives.
Oncode Accelerator is a public-private partnership that is funded by the Dutch National Growth Fund (NGF). It is a collaboration between six coordinating partners: Leiden University, Leiden University Medical Center, the Netherlands Cancer Institute, Princess Máxima Center, UMC Utrecht and the Oncode Accelerator Foundation.
Company Details
- Employees
- 38
- Founded
- -
- Address
- Jaarbeursplein 6, Beatrixgebouw - 5th Floor,netherlands
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.oncodeaccelerator.nl
- Keywords
- Oncology, Research, Cancer therapies, preclinical therapeutic development, cancer research, Drug Development, Drug Discovery.
- HQ
- Utrecht, Utrecht
Oncode Accelerator Questions
Oncode Accelerator's website is https://www.oncodeaccelerator.nl
Oncode Accelerator's LinkedIn profile is https://nl.linkedin.com/company/oncode-accelerator
Oncode Accelerator has
38 employees.
View email and phone details for 38
employees at Oncode Accelerator.
Oncode Accelerator's industry is
Research Services
Oncode Accelerator's top competitors are
Prinses Máxima Centrum Voor Kinderoncologie,
Oncode Institute,
Biotech Booster,
Hollandbio,
The Netherlands Cancer Institute,
Utrecht Science Park,
Mimetas,
Hubrecht Institute,
Regmed Xb,
Hub Organoids.
Oncode Accelerator's categories are Research Services
Oncode Accelerator's founding year is 2023
